NCT00761748

Brief Summary

Coloplast A/S has developed a new, improved 2-piece product for people with urostomies.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for phase_3

Timeline
Completed

Started Sep 2008

Shorter than P25 for phase_3

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2008

Completed
25 days until next milestone

First Submitted

Initial submission to the registry

September 26, 2008

Completed
3 days until next milestone

First Posted

Study publicly available on registry

September 29, 2008

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2009

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2009

Completed
3.9 years until next milestone

Results Posted

Study results publicly available

January 1, 2013

Completed
Last Updated

January 1, 2013

Status Verified

November 1, 2012

Enrollment Period

4 months

First QC Date

September 26, 2008

Results QC Date

March 8, 2010

Last Update Submit

November 29, 2012

Conditions

Keywords

Urostomy,2-piece,preference,

Outcome Measures

Primary Outcomes (1)

  • Preference of the Two Urostomy Products

    Number of participants preferring the SenSura Uro 2 piece product or the reference Convatec 2 piece product. The subjects are asked via the case report form (questionnaire) at the end of the second cross over period, which of the two products they preferred.

    6 weeks

Study Arms (2)

SenSura

EXPERIMENTAL

SenSura Uro 2-piece. Is a urostomy bag with the intended use of collecting urine from a stoma. Consist of a base plate and a bag that is attached to the base plate.

Device: SenSura Uro 2-piece

Convatec

ACTIVE COMPARATOR

Convatec Uro 2-piece Is a urostomy bag with the intended use of collecting urine from a stoma. Consist of a base plate and a bag that is attached to the base plate.

Device: Convatec Uro 2-piece

Interventions

Specific name of the device: 'Combihesive Natura® with a Durahesive Convex-It® base plate, 45 mm coupling, moldable (13-22 and 22-33 mm) hole size with boarder tape'. The subjects are asked to test each of the two products for 21 days plus/minus 3 days in a randomised order and in accordance with their normal frequency of change and normal use pattern. The duration of the clinical investigation should be enough time to identify any difference in user-preference. If the subject is in the middle of testing an urostomy base plate when the test period is turning into the next period, the urostomy base plate can be worn until it needs to be changed. It is not possible to blind the investigation as the appearance of the test- and refer-ence products are very different in the look.

Also known as: ConvaTec 2-piece
Convatec

SenSura URO 2-piece Extended Wear, convex light, 50 mm coupling, cuttable (15-33 mm)

Also known as: SenSura
SenSura

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Be at least 18 years old,
  • Be able to complete a written consent form
  • Be able to fill in the Case Report Form
  • Have a urostomy with a diameter of 33 mm. or less.
  • Have had the urostomy for 3 months or more.
  • Use a 2-piece convex (or convex light) normally.
  • Be able to use SenSura URO 2-piece product
  • Be able to use ConvaTec, 2-piece product
  • Be able to handle the product themselves (application, removal and emptying),

You may not qualify if:

  • In order to be enrolled in the clinical investigation, the subjects must not:
  • Need to use an ostomy belt
  • Be currently suffering from any dermatological problems, needing special treatment, on the peristomal skin
  • Being treated with chemo- or radiation therapy,
  • Be hospitalized during study enrollment, or have a hospitalization or significant surgery planned during the 4-week study period, or
  • Be pregnant or breast-feeding.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Visé Mitteldeutschland GmbH

Magdeburg, 39114, Germany

Location

Results Point of Contact

Title
Director of Medical Outcome
Organization
Coloplast A/S

Study Officials

  • Daniel Carter, M.Sc

    Coloplast A/S

    STUDY CHAIR

Publication Agreements

PI is Sponsor Employee
No
Restriction Type
LTE60
Restrictive Agreement
Yes

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
NONE
Intervention Model
CROSSOVER
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 26, 2008

First Posted

September 29, 2008

Study Start

September 1, 2008

Primary Completion

January 1, 2009

Study Completion

February 1, 2009

Last Updated

January 1, 2013

Results First Posted

January 1, 2013

Record last verified: 2012-11

Locations